# An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.

Source: https://onco.cc/trials/nct07282262/  
OnCo record `nct07282262` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of lenvatinib and ivosidenib in gallbladder cancer and other biliary tract cancers, run by Peking Union Medical College Hospital, now recruiting.

## Summary

An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy. is a phase 2 interventional study registered as NCT07282262 by Peking Union Medical College Hospital, with a registry enrolment figure of 300 participants, started 2024-05-01 and due to reach its primary completion in 2026-10-01. Interventions recorded: Ivosidenib, Lenvatinib, PD-1/PD-L1 inhibitor. Conditions listed: Biliary Tract Cancer. Sites: China. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-24
- Tags: ctgov-ingest; gallbladder-deep-dive
- Registry id: NCT07282262
- Phase: 2
- Setting: An Exploratory Study on the Use of Ivosidenib for the Precise Treatment of Advanced Biliary Tract Malignancies With IDH1 Mutations in the Later Line of Therapy.
- Sponsor: Peking Union Medical College Hospital
- Enrolled: 300

## Sources

- ClinicalTrials.gov NCT07282262: https://clinicaltrials.gov/study/NCT07282262

## Connected records

- cancers: [Biliary tract cancer (all types)](https://onco.cc/cancers/biliary-tract-cancer/), [Biliary tract cancer (cholangiocarcinoma)](https://onco.cc/cancers/cholangiocarcinoma/), [Gallbladder cancer](https://onco.cc/cancers/gallbladder/)
- technologies: [IDH inhibitors](https://onco.cc/technologies/idh-inhibitors/), [Small-molecule kinase inhibitors](https://onco.cc/technologies/kinase-inhibitors/)
- drugs: [Ivosidenib](https://onco.cc/drugs/ivosidenib/), [Lenvatinib](https://onco.cc/drugs/lenvatinib/)
- terms: [Gallbladder cancer in biliary tract cancer trials (eligibility and subgroups)](https://onco.cc/terms/gallbladder-cancer-in-biliary-trials/)

---
JSON: https://onco.cc/api/v1/entities/nct07282262.json